Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Watson CEO Seeks Brand-Drug Profits in Shift From Copycats
Watson CEO Seeks Brand-Drug Profits in Shift From Copycats
Watson CEO Seeks Brand-Drug Profits in Shift From Copycats
Submitted by
admin
on February 9, 2012 - 11:49am
Source:
Bloomberg
News Tags:
Watson
Pharma CEOs
generics
Paul Bisaro
M&A
branded pharma
Headline:
Watson CEO Seeks Brand-Drug Profits in Shift From Copycats
Do Not Allow Advertisers to Use My Personal information
